CD19 chimeric antigen receptor T-cell therapy improved lung function and skin thickness in patients with severe refractory ...
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were ...
Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal fourth quarter and fiscal year ended September 27, 2025, and guidance for our ...
Dan Caruso considered locating in Silicon Valley, Boston or Washington, D.C., when he left WorldCom Inc. to start his own ...
The United States is grappling with a staggering national debt that has surged to $38 trillion by late 2024. This alarming ...